OCX - Oncocyte Corporation
Previous close
3.1427
0 0%
Share volume: 8,688
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.14
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-12 | 2022-11-10 | 2023-04-12 | 2023-05-15 | 2023-08-10 | 2023-11-09 | 2024-04-16 | 2024-05-15 | |
| Total revenue | 2.067 M | 1.017 M | -3.550 M | 297.000 K | 463.000 K | 429.000 K | 314.000 K | 176.000 K | |
| Cost of revenue | 2.381 M | 2.191 M | -5.553 M | 287.000 K | 191.000 K | 181.000 K | 431.000 K | 274.000 K | |
| Gross profit | -314.000 K | -1.174 M | 2.003 M | 10.000 K | 272.000 K | 248.000 K | -117.000 K | -98.000 K | |
| -273.89% | 270.61% | -99.50% | 2,620.00% | -8.82% | -147.18% | 16.24% | |||
| Operating expenses | 14.607 M | 14.189 M | -12.500 M | 6.234 M | 6.771 M | 5.385 M | 4.881 M | 5.688 M | |
| Selling general and admin | 9.033 M | 9.768 M | -4.678 M | 4.107 M | 4.336 M | 3.200 M | 2.334 M | 3.519 M | |
| Research and development | 5.574 M | 4.421 M | -7.822 M | 2.127 M | 2.435 M | 2.185 M | 2.547 M | 2.169 M | |
| Total expenses | 16.988 M | 16.380 M | -18.053 M | 6.521 M | 6.962 M | 5.566 M | 5.312 M | 5.962 M | |
| -3.58% | -210.21% | 136.12% | 6.76% | -20.05% | -4.56% | 12.24% | |||
| Operating income | -14.921 M | -15.363 M | 14.503 M | -6.224 M | -6.499 M | -5.137 M | -4.998 M | -5.786 M | |
| Ebit | -14.921 M | -15.363 M | 14.503 M | -6.224 M | -6.499 M | -5.137 M | -4.998 M | -5.786 M | |
| Pretax income | -8.300 M | -9.333 M | 9.312 M | 5.959 M | -8.333 M | -6.489 M | -15.992 M | -9.129 M | |
| 12.45% | -199.77% | -36.01% | -239.84% | -22.13% | 146.45% | -42.92% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -8.300 M | -9.555 M | -45.276 M | 3.033 M | -8.644 M | -6.687 M | -16.425 M | -9.129 M | |
| -15.12% | -373.85% | 106.70% | -385.00% | 22.64% | -145.63% | 44.42% | |||
| Net income | -8.300 M | -9.555 M | -45.276 M | 3.033 M | -8.644 M | -6.687 M | -16.425 M | -9.129 M | |
| -15.12% | -373.85% | 106.70% | -385.00% | 22.64% | -145.63% | 44.42% |